pcs6422
·Code: PCS6422
pcs6422: 1 clinical trial tracked.
pcs6422 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about pcs6422, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 2, Open-Label Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
Primary endpoint: Evaluation of Objective Response Rate (ORR)
InterventionalRandomizedopen20 enrolledStarted 2024-10Completion 2026-0712 sites · United StatesProcessa Pharmaceuticals